Fungal pneumonia

Revision as of 18:38, 7 September 2012 by Priyamvada Singh (talk | contribs)
Jump to navigation Jump to search

Pneumonia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pneumonia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

Diagnostic Algorithm

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Other Imaging Findings

Treatment

Medical Therapy

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Fungal pneumonia On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Fungal pneumonia

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Fungal pneumonia

CDC onFungal pneumonia

Fungal pneumonia in the news

Blogs on Fungal pneumonia

Directions to Hospitals Treating Pneumonia

Risk calculators and risk factors for Fungal pneumonia

Editor(s)-in-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753; Philip Marcus, M.D., M.P.H.[2]

Pneumonia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pneumonia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

Diagnostic Algorithm

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Other Imaging Findings

Treatment

Medical Therapy

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Fungal pneumonia On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Fungal pneumonia

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Fungal pneumonia

CDC onFungal pneumonia

Fungal pneumonia in the news

Blogs on Fungal pneumonia

Directions to Hospitals Treating Pneumonia

Risk calculators and risk factors for Fungal pneumonia

For patient information click here

Editor(s)-in-Chief: C. Michael Gibson, M.S., M.D. [3] Phone:617-632-7753; Philip Marcus, M.D., M.P.H.[4]

Overview

Historical Perspective

Pathophysiology

Causes

Specific causes: Bacterial | Fungal | Parasitic | Viral
Classification scheme: Community-acquired pneumonia | Health-care associated pneumonia
Other types: Severe acute respiratory syndrome | Bronchiolitis obliterans organizing pneumonia | Eosinophilic pneumonia | Chemical pneumonia | Aspiration pneumonia

Differentiating Pneumonia from other Diseases

Epidemiology and Demographics

Risk factors

Natural History, Complications and Prognosis

Prognosis predictor scores: CURB-65 | Pneumonia severity index | Criteria for severe community acquired pneumonia

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT

Treatment

Site of care decision | Medical Therapy | Other treatments consideration | Prevention | Management of non-responding pneumonia

Template:WH Template:WS


Overview

Fungal pneumonia is an infection of the lungs by fungi. It can be caused by either endemic or opportunistic fungi or a combination of both.Fungal pneumonia is uncommon, but it may occur in individuals with immune system problems due to AIDS, immunosuppresive drugs, or other medical problems. The pathophysiology of pneumonia caused by fungi is similar to that of bacterial pneumonia. Fungal pneumonia is most often caused byHistoplasma capsulatum, Cryptococcus neoformans, Pneumocystis jiroveci, and Coccidioides immitis.Histoplasmosis is most common in the Mississippi River basin, and coccidioidomycosis in the southwestern United States.

Pathophysiology & Etiology

Fungi typically enter the lung with inhalation of their spores, though they can reach the lung through the bloodstream if other parts of the body are infected. Also, fungal pneumonia can be caused by reactivation of a latent infection. Once inside the alveoli, fungi travel into the spaces between the cells and also between adjacent alveoli through connecting pores. This invasion triggers the immune system to respond by sending white blood cells responsible for attacking microorganisms (neutrophils) to the lungs. The neutrophils engulf and kill the offending organisms but also release cytokines which result in a general activation of the immune system. This results in the fever, chills, and fatigue common in bacterial and fungal pneumonia. The neutrophils and fluid leaked from surrounding blood vessels fill the alveoli and result in impaired oxygen transportation.

Etiologic agent

Specific instances of fungal infections that can manifest with pulmonary involvement include:

Risk Stratification and Prognosis

Case mortality in fungal pneumonias can be as high as 70% in immunocompromised patients, though immunocompetent patients generally respond well to anti-fungal therapy.

Treatment

Fungal pneumonia can be treated with antifungal drugs and sometimes by surgical debridement.

References

Template:WH Template:WS